MARKET

GHRS

GHRS

Gh Research Plc
NASDAQ
12.45
+0.75
+6.41%
After Hours: 13.07 +0.62 +4.98% 17:23 05/20 EDT
OPEN
11.75
PREV CLOSE
11.70
HIGH
13.25
LOW
11.71
VOLUME
572.03K
TURNOVER
--
52 WEEK HIGH
20.50
52 WEEK LOW
6.00
MARKET CAP
772.25M
P/E (TTM)
-15.8035
1D
5D
1M
3M
1Y
5Y
1D
Psychedelic stocks rise as FDA chief’s comments seen favorable to industry
Seeking Alpha · 10h ago
Weekly Report: what happened at GHRS last week (0512-0516)?
Weekly Report · 1d ago
GH Research Showcases Promising Depression Treatment Data at ASCP Meeting
TipRanks · 5d ago
GH Research announces acceptance of presentation at ASCP
TipRanks · 5d ago
Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS) and GH Research (GHRS)
TipRanks · 05/13 01:51
Weekly Report: what happened at GHRS last week (0505-0509)?
Weekly Report · 05/12 10:17
GH Research: Promising Clinical Results and Strong Financial Position Justify Buy Rating
TipRanks · 05/09 19:25
GH Research Is Maintained at Buy by Guggenheim
Dow Jones · 05/09 16:48
More
About GHRS
GH Research PLC is a clinical-stage biopharmaceutical company. The Company is engaged in offering treatment for psychiatric and neurological disorders. The Company's pipeline includes GH001, GH002 and GH003. The Company focuses on developing its 5- Methoxy-N, N-Dimethyltryptamine, (5-MeO-DMT), therapies for the treatment of patients with Treatment Resistant Depression (TRD). Its product candidate, GH001, is formulated for 5-MeO-DMT administration via an inhalation approach. With GH001, the Company has completed two Phase 1 healthy volunteer clinical trials and a Phase 1/2 clinical trial in patients with treatment-resistant depression (TRD). The GH002 is a 5-MeO-DMT product candidate formulated for administration via an injectable approach. GH002 has completed pre-clinical development to support early clinical trials. The GH003 is a 5-MeO-DMT product candidate formulated for administration via an intranasal administration approach.

Webull offers GH Research PLC stock information, including NASDAQ: GHRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GHRS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GHRS stock methods without spending real money on the virtual paper trading platform.